Key facts
- Visby Medical’s last known valuation is $866.0M (May 2020).
- It has raised $486.6M across 1 recorded rounds; the latest was Later Stage VC ($108.6M) in Feb 2022.
- Notable investors include Plug and Play Tech Center, National Institutes of Health, Amplify Partners, Catalio Capital Management, Lightrock — 35 tracked in total.
- Visby Medical has filed 1 Form D with the SEC, most recently Mar 2022 ($108.6M sold to 45 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 35 names
- ·Watchlist + deal alerts for Visby Medical
Funding rounds
1 roundsAbout Visby Medical
Developer of polymerase chain reaction (PCR) based diagnostic testing devices designed for the detection of infectious diseases. The company's platform PCR results in under half an hour, requires no additional instruments or maintenance, enabling healthcare providers to diagnose and treat patients during a single visit, improving patient outcomes, and reducing the need for follow-up appointments.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2012
- Employees
- 208
- Website
- visby.com/
- Ownership
- Privately Held (backing)
Visby Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Visby Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Visby Medical in its N-PORT filings yet. We sweep new filings monthly.